Royalty Report: Medical, Supply – Collection: 1672

$100.00

Curated Royalty Rate Report
Category: Technology Licenses, Created On: 2022-04-28, Record Count: 3

Description

This collection of transactions and supporting information was developed using our AI algorithm to curate similar royalty reports into a cohesive collection to support your licensing, transfer pricing or other transaction scenarios where documented royalty rates and/or deal terms are important.
Category: Technology Licenses
Created On: 2022-04-28
Record Count: 3

Primary Industries

  • Medical
  • Supply

IPSCIO Report Record List

Below you will find the records curated into this collection.  This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs.  The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms.  For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report

IPSCIO Record ID: 1672

License Grant
Israeli Licensor has assigned the worldwide rights to its patent applications, any patents which may issue and know-how to develop, manufacture and market products relating to in-situ tissue culturing technology; in-situ tissue culturing technology utilized proprietary, defined, serum-free combinations of nutrients and hormones which, when applied to the body, promoted cell growth.

IPSCIO Record ID: 5464

License Grant
The Licensee announced the settlement of its ongoing litigation with the Licensor relates to a tissue-grafting technology–tissue engineering patents, trade secrets and know-how relating to tissue decellularization and recellularization.
License Property
This technology is used in heart valves and vascular grafts.

Orton Patents include, but are not limited to, U.S. Patent Nos. 5,192,312; 5,772,695; 5,863,296; 5,855,617, and U.S. Provisional Application Serial No. 60/219,548 as well as corresponding Non-Provisional Application Serial No. 09/909914 and PCT Application Serial No. PCT/US01/22018.  
Goldstein Patents shall mean U.S. Patent Nos. 5,613,982; 5,632,778; 5,843,182; 5,899,936; and all pending and future applications and patents, both U.S. and foreign, arising from these patents, as well as any continuations, continued prosecution applications, continuations-in-part, divisions, or substitutions thereof.  

Tissue Decellularization Patent Applications shall mean U.S. Application Serial Nos. 08/838,852 and 09/735,522 and all pending and future applications.  

Tissue Graft Patent Applications shall mean U.S. Application Serial Nos. 60/178,632 and 09/769,769 and all pending and future applications and patents.

Unstented Heart Valve Patent Applications shall mean U.S. Application Serial No. 09/540,525 and all pending and future applications and patents, both U.S. and foreign, arising from these patents, as well as any continuations, continued prosecution applications, continuations-in-part, divisions, or substitutions thereof.

IPSCIO Record ID: 7150

License Grant
Licensor, a director and executive officer of the Company, hereby grants the Company the right to manufacture the Flasks solely for its own use, and to use the Technical Information in connection therewith. The licenses granted herein shall commence as of the execution date of this Agreement and shall continue for the entire unexpired term of U.S. Patent No. 6,403,369 and any patent issuing from U.S. Patent Application No. 11/677,933. No other right or license is granted to Licensee and Licensor shall retain the rights to license the Flask Inventions for all other purposes not explicitly licensed to Licensee, except as may be restricted pursuant of this Agreement.
License Property
Licensor is the owner of U.S. Patent No. 6,403,369 entitled “CELL CULTURE VESSEL” (which relates to the design of a flask), issued on June 11, 2002, and has a pending patent application (U.S. Patent Application Serial No. 11/677,933 entitled “MULTI- COMPARTMENT CELL CULTURE VESSEL”) that was filed on February 22, 2007 relating to the modification of the patented flask design (such intellectual property relating to U.S. Patent No. 6,403,369 and U.S. Patent Application No. 11/677,933 being hereinafter referred to as the “Flask Inventions” or the “Flasks”).
Disclaimer: The information gathered from RoyaltySource® database was sourced from the U.S. Securities and Exchange Commission EDGAR Filings and other public records. While we believe the sources to be reliable, this does not guarantee the accuracy or completeness of the information provided. Further, the information is supplied as general guidance and is not intended to represent or be a substitute for a detailed analysis or professional judgment. This information is for private use only and may not be resold or reproduced without permission.